glp-1 news today october 2025 obesity drug therapies are changing care. What does WHO recommend? Here's what you need to know obesity drug news today october – GLP-1 Drugs: 2025 Pulse Survey

Compounded GLP-1s have not been evaluated by the FDA, but side effects are expected to be similar to other GLP-1-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)

Nephrol Dial.Transplant

For some, this may be a bit too hands-off

To get 500mcg/mL: You will add exactly 2mL (or two full 1mL syringes) of bacteriostatic water to the 1mg vial